{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:56:08Z","timestamp":1792418168740,"version":"4.4.0"},"reference-count":28,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2016,2,5]],"date-time":"2016-02-05T00:00:00Z","timestamp":1454630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Leukemia & Lymphoma"],"published-print":{"date-parts":[[2016,4,2]]},"DOI":"10.3109\/10428194.2016.1140760","type":"journal-article","created":{"date-parts":[[2016,2,6]],"date-time":"2016-02-06T01:08:47Z","timestamp":1454720927000},"page":"783-788","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["How to select the frontline treatment for a patient with peripheral T-cell lymphoma"],"prefix":"10.3109","volume":"57","author":[{"given":"Stephen","family":"Ansell","sequence":"first","affiliation":[{"name":"Mayo Clinic","place":["Rochester, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2016,2,5]]},"reference":[{"key":"e_1_3_1_2_1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"Steven H","year":"2008","unstructured":"Steven H, Swerdlow EC, Harris NL, et\u00a0al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon, France: International Agency for Research on Cancer; 2008.","edition":"4"},{"key":"e_1_3_1_3_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.11.3909"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V84.5.1361.1361"},{"key":"e_1_3_1_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.4558"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-04-571091"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdp418"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.6.2296"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-09-3080"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdh392"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.17.4870"},{"key":"e_1_3_1_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08329.x"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq635"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0469-9"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-02-074641"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.742521"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-270785"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.2719"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.2456"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.504.504"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.253.253"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.27733"},{"key":"e_1_3_1_23_1","article-title":"A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T-cell consortium trial.","author":"Advani RH","year":"2015","unstructured":"Advani RH, Ansell SM, Lechowicz MJ, et\u00a0al. A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T-cell consortium trial. Br J Haematol. 2015. doi:10.1111\/bjh.13855.[Epub ahead of print].","journal-title":"Br J Haematol"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10737"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.52.7911"},{"key":"e_1_3_1_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.8.2966"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.23.8295"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.35.6287"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06371.x"}],"container-title":["Leukemia & Lymphoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2016.1140760","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.3109\/10428194.2016.1140760","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/10428194.2016.1140760","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T13:31:40Z","timestamp":1792416700000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/10428194.2016.1140760"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,5]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4,2]]}},"alternative-id":["10.3109\/10428194.2016.1140760"],"URL":"https:\/\/doi.org\/10.3109\/10428194.2016.1140760","relation":{},"ISSN":["1042-8194","1029-2403"],"issn-type":[{"value":"1042-8194","type":"print"},{"value":"1029-2403","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,5]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ilal20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2016-01-03","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-01-07","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-02-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}